Preclinical studies demonstrated that GLP-1 receptor agonists increased bone formation and reduced bone resorption in metabolic bone disease models, including diabetic osteoporosis, postmenopausal osteoporosis, and glucocorticoid-induced osteoporosis
This work was supported by the National Key Research and Development Program of China (2023YFC2306002), the National Natural Science Foundation of China (82372227 and 82172245), the Beijing Natural Science Foundation (L256024, 7264275), the High-level Talents Program of the Beijing Health System, and Funding for Reform and Development of Beijing Municipal Health Commission (EYGF-BD-03)
Several studies have, for instance, confirmed the presence of increased oxidative stress in plasma in patients with ASD (126)
BPC-157 is widely researched for its potential role in tissue regeneration, angiogenesis, connective tissue repair, inflammatory pathways, and gastrointestinal biology
A murine macrophage cell line exposed to S
The emotional aspect of the disorder can be managed with continued sun protection